NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 132 filers reported holding NOVAVAX INC in Q4 2013. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $104,000 | -34.6% | 50,000 | +122.2% | 0.10% | -30.2% |
| Q3 2015 | $159,000 | -28.7% | 22,500 | +12.5% | 0.15% | +7.2% |
| Q2 2015 | $223,000 | -24.4% | 20,000 | -44.0% | 0.14% | -29.4% |
| Q1 2015 | $295,000 | -1.0% | 35,720 | -28.8% | 0.20% | +23.1% |
| Q4 2014 | $298,000 | +77.4% | 50,200 | +24.9% | 0.16% | +34.5% |
| Q3 2014 | $168,000 | -16.0% | 40,200 | -6.9% | 0.12% | -4.0% |
| Q2 2014 | $200,000 | -48.1% | 43,200 | -49.2% | 0.12% | -40.4% |
| Q1 2014 | $385,000 | -24.8% | 85,000 | -15.0% | 0.21% | -15.8% |
| Q4 2013 | $512,000 | – | 100,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |